Arcus Biosciences, Inc. (NYSE:RCUS) Expected to Post FY2024 Earnings of ($2.64) Per Share
Arcus Biosciences, Inc. (NYSE:RCUS – Free Report) – Stock analysts at Wedbush raised their FY2024 EPS estimates for Arcus Biosciences in a research report issued on Tuesday, January 30th. Wedbush analyst R. Driscoll now forecasts that the company will post earnings per share of ($2.64) for the year, up from their previous estimate of ($4.11). […]
More Stories
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
CION Investment Co. (NYSE:CION) to Issue $0.05 Annual Dividend
CION Investment Co. (NYSE:CION – Get Free Report) announced an annual dividend on Monday, December 23rd,NASDAQ Dividends reports. Shareholders of...
EOG Resources (EOG) – Analysts’ Weekly Ratings Updates
EOG Resources (NYSE: EOG) has recently received a number of price target changes and ratings updates: 12/20/2024 – EOG Resources...
EOG Resources (EOG) – Analysts’ Weekly Ratings Updates
EOG Resources (NYSE: EOG) has recently received a number of price target changes and ratings updates: 12/20/2024 – EOG Resources...
Head-To-Head Comparison: General Enterprise Ventures (GEVI) and Its Peers
Earnings & Valuation This table compares General Enterprise Ventures and its peers top-line revenue, earnings per share and valuation. Gross...
Head-To-Head Comparison: General Enterprise Ventures (GEVI) and Its Peers
Earnings & Valuation This table compares General Enterprise Ventures and its peers top-line revenue, earnings per share and valuation. Gross...